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The construction of nanostructures from biodegradable precursors and shell/core crosslinking have been
pursued as strategies to solve the problems of toxicity and limited stability, respectively. Polyphosphoester
(PPE)-based micelles and crosslinked nanoparticles with non-ionic, anionic, cationic, and zwitterionic
surface characteristics for potential packaging and delivery of therapeutic and diagnostic agents, were
constructed using a quick and efficient synthetic strategy, and importantly, demonstrated remarkable
differences in terms of cytotoxicity, immunotoxicity, and biofouling properties, as a function of their surface
characteristics and also with dependence on crosslinking throughout the shell layers. For instance,
crosslinking of zwitterionic micelles significantly reduced the immunotoxicity, as evidenced from the
absence of secretions of any of the 23measured cytokines fromRAW264.7mousemacrophages treatedwith
the nanoparticles. The micelles and their crosslinked analogs demonstrated lower cytotoxicity than several
commercially-available vehicles, and their degradation products were not cytotoxic to cells at the range of
the tested concentrations. PPE-nanoparticles are expected to have broad implications in clinical
nanomedicine as alternative vehicles to those involved in several of the currently available medications.
P
olymeric nanoparticles have demonstrated high efficiency in the delivery of various drugs (e.g. chemother-
apeutics, nucleic acids and antimicrobial drugs) and several of them are currently in the market, under
clinical trials or still in the laboratory research stage undergoing rigorous in vitro and in vivo investi-
gations1–4. Among the many challenges towards clinical utilization of these nanoparticulates, two significant
barriers to overcome are induction of various adverse biological reactions (i.e. toxicity, hypersensitivity, throm-
bosis, immunomodulatory effects, etc.) and destabilization before reaching their target sites or tissues5,6. The
construction of nanostructures from degradable precursors and shell/core crosslinking has been pursued as
strategies to solve the problems of toxicity and limited stability, respectively. Designing degradable nanomaterials
is currently receiving great impetus due to their ability to degrade after delivering their therapeutic cargoes. In
addition, the degradation rate might be tuned via incorporating various functionalities to control the degradation
and/or to respond to a particular enzyme or pH, and hence allowing for controlled or stimuli-responsive drug
delivery applications7,8. Although it is well known that nanoparticle surface charge influences their toxicities, this
study reveals a delicate balance between nanoparticle composition, surface charge and stability on their biological
responses.
Interactions between nanoparticles and the various components of the immune system can result in immu-
nomodulatory effects, hence, avoiding recognition by the immune system is a straightforward strategy to over-
come nanoparticle-induced toxicity9. The structure, composition, shape and surface chemistries of nanomaterials
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dictate the type and extent of their interactions with the immune
system components and thus the resulting immune response9,10.
Evaluation of the immunotoxicity of nanomaterials, partially, by
measuring the levels of cytokines, in particular the proinflammatory
cytokines, can be a useful tool in evaluating nanoparticle immuno-
toxicity9. High levels of cytokines upon treatment with nanoparticles
are usually associated with toxicity, adverse reactions and low thera-
peutic efficacy9,11. Crosslinking of one or more of the compartments
of the polymeric nanomaterials forms robust structures that have
lower tendency of dissociation and aggregation than their micellar
analogs and also allows to control the release rates of cargos12. In
addition, the presence of stabilizing crosslinks has been shown
recently to induce lower toxicity and immunotoxicity, as compared
to their micellar counterparts, eventually due to limiting the release
of free polymeric units and reducing the interactions with the sur-
rounding cells and biomacromolecules13,14.
Rapid and efficient synthesis and construction of nanomaterials
are major concerns for translation into clinically-viable products15,16.
Recently, we have developed an efficient and rapid synthetic strategy
to program a series of polyphosphoester (PPE)-based micelles with
various surface charges17,18. In this study, the effects of shell-
crosslinking and surface charges on the degradation rate, protein
adsorption and toxicity profiles of the neutral, anionic, cationic
and zwitterionic micelles were studied. PPE-micelles and crosslinked
nanoparticles were constructed via a rapid and efficient strategy that
yielded nanosized particles with narrow size distributions, and
versatile structures and surface chemistries. These nanoparticles
demonstrated remarkable safety profiles and, hence, they are
expected to have broad implications in clinical nanomedicine as
alternative vehicles to those involved in several of the currently avail-
able medications.
Results
Polyphosphoester nanoparticles: self-assembly and shell cross-
linking. PPE-based nanoparticles with different surface charges
and shell-crosslinking extents were constructed, and their degrada-
tion kinetics and immunotoxicities were studied. Recently, we have
developed a synthetic strategy to program a series of diverse, func-
tionalmicelles with various surface charges from reactivemonomers,
in which all three steps are rapid, quantitative and conducted under
mild conditions17,19. The hydrophobic-functional AB diblock PPE,
poly(2-ethylbutyl phospholane)-block-poly(butynyl phospholane)
(PEBP-b-PBYP) was synthesized by an ultrafast (,5 min) organo-
catalyzed ring-opening polymerization in a one-pot manner and was
transformed into four amphiphilic diblock copolymers with different
charges by ‘‘click’’ type thiol-yne reactions, which were then assem-
bled into polymer micelles by direct dissolution into water20. In this
study, those four types of polymeric micelles with different surface
charges/functionalities, 1–4, were constructed via self-assembly of
non-ionic, anionic, cationic and zwitterionic diblock copolymers,
and then the anionic, cationic and zwitterionic micelles (2–4) were
further transformed through shell crosslinking reactions into stable
shell-crosslinked knedel-like nanoparticles (SCKs, 5–7), as shown in
Figure 1.
Four micelles were self-assembled from four amphiphilic diblock
copolymers while three SCKs were constructed by shell crosslinking
of the three charged micelles that possessed functionalities through
which the crosslinking reactions could be performed. All four amphi-
philic diblock PPEs were dissolved in nanopure water by sonication
for 5 min and spontaneously formed spherical micelles, 1, 2, 3 and 4,
with narrow size distributions (see previous publication17 for the
characterization data). Three chargedmicelles were shell-crosslinked
with different reagents via amidation reactions. To form the anionic
SCKs, 5, the carboxylic acid groups on the hydrophilic segment of
diblock copolymer, which were located in shell domains of the
anionic micelles, 2, were activated by 1-[39-(dimethylamino)pro-
pyl]-3-ethylcarbodiimide methiodide (EDCI) to react with the di-
amine compound, 2,29-(ethylenedioxy)bis(ethylamine). This same
strategy was applied to the construction of cationic SCKs, 6, by
coupling of the di-acid compound, Bis-dPEGH2-acid with amino
groups in the shell domains of the cationic micelles, 3, facilitated
by the addition of EDCI. Since the shell domain of the zwitterionic
micelle, 4, contained both amino groups and carboxylic acid groups,
EDCI was used to activate their coupling without using additional
reagents in the construction of the zwitterionic SCKs, 7. Due to the
unavailability of chemical functionalities in the shell domain of
the non-ionic micelle, 1, preparation of a shell-crosslinked form of
the non-ionic nanoparticle was not feasible. After the nominal 30%
shell-crosslinking, SCK solutions were purified by extensive dia-
lysis against nanopure water in the cold room to remove small
compounds.
The sizes and size distributions of the three SCKs were character-
ized by both transmission electron microscopy (TEM) and dynamic
light scattering (DLS), as shown in Figure 2. The circularly-shaped
images observed by TEM suggested that these nanoparticles main-
tained micellar structure after the shell crosslinking. TEM images of
5, 6, and 7 showed uniform nanoparticles with average sizes of
approximately 16, 16 and 23 nm, respectively (Figures 2a, 2c, 2e).
DLS results showed narrow and mono-modal size distributions of
nanoparticles in all three SCKs. The number-averaged hydrodyn-
amic diameters (Dh(number)) of 5, 6 and 7 were 16 6 4 nm, 15 6
3 nm and 23 6 6 nm, respectively (Figures 2b, 2d, 2f). The main-
tenance of the SCK dimensions with their corresponding micelles
indicated that inter-particle crosslinking was not prevalent during
the intra-particle crosslinking process. By shell-crosslinking, three
charged micelles were transferred into three robust SCKs without
changing their sizes or size distributions.
The zeta-potential values were measured for the four micelles and
three SCKs in buffer solutions at pH 5.0 and pH 7.4 by Delsa Nano C
particle analyzer (Figure 3). The non-ionic micelle, 1, had slightly
negative zeta potentials of212.2 mV at pH 7.4 and218.0 mV at pH
5.0. The negative-charged nature of the anionic micelles, 2, and
anionic SCKs, 5, was confirmed through zeta potential measure-
ments. After the shell crosslinking, 5maintained low zeta potentials,
234.7 mV at pH 7.4 and 228.4 mV at pH 5.0, which were slightly
higher than those of 2 due to the partial consumption of carboxylic
acid groups during the shell crosslinking process. Similarly, the
cationic SCKs, 6, sustained the positive zeta potentials at both pH
7.4 and pH 5.0, but to a lesser extent, as compared to the cationic
micelles 3, due to the consumption of some amino groups for the
shell crosslinking. Since the shell crosslinking of zwitterionicmicelles
consumed both the carboxylic and amino groups, the resulting zwit-
terionic SCKs, 7, had zeta potentials at both pH 7.4 and pH 5.0 that
were similar to their micellar analogs 4. The zeta potential measure-
ments confirmed the expected surface charges and surface function-
alities of the four micelles and three SCKs.
Effect of pH, surface chemistry and crosslinking on degradation
profiles of PPE-nanoparticles. PPE nanoparticles are attractive for
biomedical applications mainly because of their biodegradability and
chemical compositional versatility, which was expected to allow for
tuning of their rates of degradation and the accommodation of drugs
having various structures, solubilities and sizes. These nanoparticles
undergo degradation either by spontaneous hydrolysis or in the
presence of certain enzymes, due to the cleavage of their phospho-
diester backbones and phosphoester side chains. Penczek and co-
workers first investigated the hydrolytic degradation kinetics of
poly(methyl ethylene phosphate) and poly(trimethylene phosph-
ate) by direct titrimetric and NMR methods21. They found that the
hydrolysis rates of the polymers were comparable to those of small
molecule model compounds, and were strongly dependent on pH;
increasing more than 100 times between acidic (pH 5 1)/basic
www.nature.com/scientificreports
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(pH 5 13) and neutral (pH 5 7) conditions. The results from several
other groups also demonstrated that PPE-based nanoparticles22–24
and hydrogels25–28 were relatively stable in neutral conditions for
dozens of days and up to several months, and accelerated degra-
dations in acidic and basic conditions were noted, as monitored by
gel permeation chromatography (GPC) andNMR spectroscopy. The
hydrolytic degradation rates were controllable by adjusting the
chemical structure in the backbone or side chain, for instance,
amino group-containing cationic PPEs degraded at accelerated
rates29,30. The hydrolytic degradation products exhibited good
Figure 1 | Schematic representation of the self-assembly of four amphiphilic diblock copolymers into non-ionic micelle (1), anionic micelle (2),
cationic micelle (3) and zwitterionic micelle (4), and the shell-crosslinking of resulting three charged micelle into anionic SCKs (5), cationic SCKs (6)
and zwitterionic SCKs (7). Adapted and modified with permission from reference17. Copyright (2013) American Chemical Society.
Figure 2 | (a), TEM image of 5, average diameter is 16 6 3 nm, after counting more than 100 particles. (b), DLS results of 5: Dh(intensity) 5 25 6 8 nm,
Dh(volume) 5 19 6 6 nm, Dh(number) 5 16 6 4 nm, PDI 5 0.06. (c), TEM image of 6, average diameter is 16 6 4 nm, after counting more than 100
particles. (d), DLS results of 6: Dh(intensity) 5 23 6 7 nm, Dh(volume) 5 18 6 5 nm, Dh(number) 5 15 6 3 nm, PDI 5 0.04. (e), TEM image of 6,
average diameter is 21 6 5 nm, after counting more than 100 particles. (f), DLS results of 7: Dh(intensity) 5 55 622 nm, Dh(volume) 5 31 6 12 nm,
Dh(number) 5 23 6 6 nm, PDI 5 0.07. All scale bars in TEM images are 100 nm.
www.nature.com/scientificreports
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biocompatibility to several cell lines24,26–28. Since PPE nanoparticles
share the structural similarity of some naturally-existing polymers
(e.g. nucleic and teichoic acids), and phosphoester bonds are widely
represented in living systems, researchers are actively looking for
enzymes for the specific and accelerated degradation of PPE-based
materials. Minor degradation of PPE nanoparticles was observed in
the presence of Pseudomonas lipase for 24 h, after the degradation of
the poly(e-caprolactone) (PCL) segment of PCL-b-PPE copolymers,
monitored by GPC31,32. Phosphoester-specific enzymes (e.g. alkaline
phosphatase) were found to accelerate the degradation of PPE-based
hydrogels at pH 9.033. Phosphodiesterase I also promoted the
degradation of PPE-based micelles/nanogels at pH 8.832,34, and
expedited the release of drug encapsulated in the nanoparticles35–37.
To investigate the hydrolytic degradation of PPE-based nanopar-
ticles with different surface charges and shell-crosslinking extent
under physiological conditions, we monitored the sizes and surface
charges of nanoparticles during the degradation when incubated in
pH 7.4 and pH 5.0 buffers at 37uC. Compared with literature
reported degradation data, this study employed DLS and zeta poten-
tial analyses tomonitor the changes in the overall nanoparticle struc-
tures and properties that were expected to influence their overall
biological interactions, instead of using NMR and GPC to track the
breakage of bonds. pH 7.4 stands for physiological environments,
while pH 5.0 is a typical pH that is commonly utilized to study the
behavior of nanoparticles to mimic the pH of endosomes/lysosomes
and the acidic pH of tumor tissues.
The non-ionic micelle, 1, had similar degradation profiles in pH
7.4 and pH 5.0 buffers, as shown in Figure S1. Non-ionic micelles
maintained their sizes at both pHs for about 4 weeks with a slight
decrease of zeta potential values. The sizes of micelles became smal-
ler, until reaching 3 nm and then became undetectable byDLS, while
the charges of the micelles became more negative until 240 mV.
This trend of becoming more negatively charged may be due to the
simultaneous hydrolysis of phosphoester linkages in the main chain
and the side chain that yielded negatively-charged phosphate groups.
Anionic micelles, 2, and anionic SCKs, 5, had different degrada-
tion profiles in terms of particle sizes, but maintained similar charges
during the degradation study (Figure S2). Both at pH 7.4 and pH 5.0
buffers, the zeta potentials of anionic micelles and anionic SCKs
slowly dropped to around 245 mV over the period of 18 weeks.
The anionic SCKs maintained their sizes for 10 weeks, and then
became smaller to 3 nm until becoming undetectable by DLS. In
contrast, the anionic micelles could maintain their sizes for only 4
weeks in pH 7.4 buffer and for 6 weeks at pH 5.0. This difference may
result from crosslinking the shell domains of micelles, which formed
structures of higher stability7. For both anionic micelles and SCKs,
the sizes decreased more gradually in pH 5.0 buffer than in pH 7.4
buffer.
Cationic micelles, 3, and cationic SCKs, 6, degraded much faster
than did the other nanoparticles. After 10 days of degradation, in
both pH 5.0 and pH 7.4 buffers, no particles could be observed by
TEM, and a signal was barely detected by DLS. The zeta potentials of
both micelles and SCKs transitioned from positive to neutral, and
finally reached a negative value of ca. 235 mV (Figure S3). This
trend may be due to the loss of cationic side groups upon hydrolysis.
Both cationicmicelles and cationic SCKs reached neutrality at pH 7.4
one day earlier than at pH 5.0. This difference may result from
intramolecular attack of the phosphoester bonds by deprotonated
amino groups. Hydrodynamic diameters of SCKs had a tendency of
getting smaller until becoming undetectable by DLS, except for the
formation of large aggregates at the isoelectric points, where zeta
potentials were almost zero. For the degradation of micelles, large
aggregates formed at the isoelectric points, but did not disappear
until the late stage. This difference may be explained by cationic
micelles undergoing re-assembly during the degradation, whereas
cationic SCKs maintained the micellar structures because of the
crosslinking of the shell domain38. The degradation study demon-
strated that PPE-based cationic nanoparticles degraded in days and
lost the cationic feature rapidly.
The degradation rates of zwitterionic nanoparticles, which main-
tained their sizes for 2–4 weeks, were between those of anionic and
cationic nanoparticles (Figure S4). The degradation of PPE-based
nanoparticles is due to the cleavage of phosphoester linkages. In
pH 7.4 and pH 5.0 buffers, the phosphorus atom may be attacked
by nucleophiles, like hydroxide or amine. More deprotonated amine
groups on the nanoparticles would result in faster degradation rate.
The degradation studies of non-ionic, anionic, cationic and zwit-
terionic micelles and SCKs demonstrated the higher stability of
SCKs. For the PPE-based nanoparticles, the one with amine groups
degraded much faster than did the others. Anionic and zwitterionic
nanoparticles would be stable in buffers for several weeks without
dramatic changes in nanoparticle sizes. The zeta potentials of all
nanoparticles decreased to 235 to 245 mV in the time windows
of their degradation profiles, days for cationic nanoparticles while
weeks for non-ionic, anionic and zwitterionic nanoparticles, indi-
cating the formation of negatively-charged phosphates in place of
the phosphoester backbone and side chain linkages. In general, the
hydrolytic degradation was slightly faster in pH 7.4 buffer than in pH
5.0 buffer.
Cytotoxicity of PPE-nanoparticles and their degradation pro-
ducts. Because of the broad ranges of chemical compositions and
Figure 3 | Zeta potential values ofmicelles 1, 2, 3, 4 and SCKs 5, 6, 7 in PBS buffer solutions at pH 7.4 and pH 5.0. The average values and their standard
deviations, from six measurements, are shown.
www.nature.com/scientificreports
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potential biomedical applications that are available for PPE-based
nanoparticulate micelles and SCKs, it was important to determine
their cytotoxicities and immunotoxicities, with comparisons being
made against commercially available vehicles. Therefore, the viabi-
lities and induced cytokine levels of RAW 264.7 mouse macrophages
were measured following 24 h incubation with increasing concen-
trations of the series of neutral, anionic, cationic, and zwitterionic
PPE micelles and SCKs, and also against Lipofectamine, polyethyle-
neimine (PEI), andCremophor-EL, with comparisons to the control-
untreated cells (Figure 4, Figure S5 and Table 1). In addition, the
degradation products of the entire series of PPE-nanoparticles (both
micelles and SCKs) were prepared by incubation in phosphate-
buffered saline (PBS) at pH 7.4 and 37uC, with continuous shaking
for 20 weeks under aseptic conditions. After complete degradation of
the nanoparticles (until no nanoparticles could be detected by dyna-
mic light scattering measurements), the solutions were lyophilized
into powders before being tested for their cytotoxicities and immu-
notoxicities. Lipofectamine, PEI and Cremophor-EL were selected as
examples of cationic (Lipofectamine and PEI) and non-ionic (Cre-
mophor-EL) vehicles that are commonly utilized for the delivery of
nucleic acids and hydrophobic drugs, respectively.
In general, the neutral (i.e. non-ionic) and zwitterionic PPE-based
micelles and SCKs were less cytotoxic than Lipofectamine, PEI and
Cremophor-EL (Table 1). For the anionic PPE-micelles, toxicity was
observed at high concentrations (3000 mg/mL). Surprisingly, the
cytotoxicity was enhanced upon crosslinking the anionic micelles.
This effect might be due to the higher stability of SCKs against
degradation (See Figure S2). Because the degradation products of
both the anionic micelles and SCKs have limited toxicity, the fas-
ter degradation of micelles into the less-cytotoxic degradation pro-
ducts might explain the lower cytotoxicity of the parent micelles as
compared to the parent SCKs. We have previously reported that
PPE-based cationic micelles had 6-fold lower cytotoxicity than
Lipofectamine17. In this study, PPE-cationic micelles were found to
have 42-fold lower cytotoxicity than PEI. Interestingly, crosslinking
of the PPE-cationic micelles yielded SCKs that were not cytotoxic up
to a concentration of 3000 mg/mL.
The degradation products of neutral, anionic, cationic and zwit-
terionic micelles and their crosslinked nanoparticle analogs did not
show any toxicity to cells up to a concentration of 3000 mg/mL,
which is an indication that the released products after degradation
do not have a considerable toxicity to cells. In a previous study,
hydrolytic degradation products of monomethyl ether poly(ethylene
glycol) (mPEG)-b-poly(ethyl ethylene phosphate) micelles were not
toxic to cells up to a concentration of 500 mg/mL24. The PPE nano-
particles developed in the current study can be rapidly synthesized
and provide versatile nanostructures (anionic, neutral, cationic or
zwitterionic), with control over their surface chemistries to accom-
modate and deliver anionic, cationic, and/or hydrophobic guest
(macro)molecules. In addition, the cytotoxicity data reveal that
PPE-based nanoparticulates may have a remarkable safety profile,
as compared to commercially-available vectors, and degradable/non-
degradable nanoparticles developed previously by our group39,40, and
by others41,42.
Anti-biofouling properties of PPE-nanoparticles. The anti-bio-
fouling properties of the series of PPE-micelles and SCKs were
studied. Briefly, nanoparticles were incubated with a fixed amount
of 23 different cytokines, and the apparent concentrations of
cytokines were measured using a multiplex assay and compared to
a solution treated in the same way but containing no nanoparticles.
The lower the apparent measured concentration of free cytokines in
the supernatant, the higher the adsorption competencies of the
nanoparticles. The adsorption of cytokines was qualitatively asse-
ssed by calculating the p values, which imply the statistical signi-
ficance of differences between the treatments and the controls
(Table 2). Although adsorption of cytokines on nanoparticles has
been observed previously43,44, it is also possible that nanoparticles
may interfere with some of the multiplex assay components (anti-
bodies, beads, etc.). The 23measured cytokines were interleukin (IL)-
1a, IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (P40), IL-12
(P70), IL-13, IL-17, Eotaxin, granulocyte-colony-stimulating factor
(G-CSF), granulocyte macrophage-colony-stimulating factor (GM-
CSF), interferon-c (IFN-c), keratinocyte-derived chemokine (KC),
monocyte chemotactic protein (MCP)-1, macrophage inflammatory
protein (MIP)-1a, MIP-1b, regulated upon activation normal T-cell
expressed and presumably secreted (RANTES) and tumor necrosis
factor-a (TNF-a).
Zwitterionic micelles and SCKs had the least adsorption of the
cytokines, a phenomenon that is in agreement with literature re-
ports45–47. The zwitterionic characteristic of nanoparticles is hypothe-
sized to impart anti-biofouling properties by electrostatically binding
water molecules more tightly than the hydrogen bonding of water in
the case of PEG and, thus, resulting in higher hydration of the corona,
which is critical in minimizing protein adsorption and generating
stealth properties48. However, we have reported recently that zwit-
terionic poly(carboxybetaine) polymeric coating resulted in higher
adsorption of cytokines, when compared to PEG, when both PEG
and poly(carboxybetaine) were grafted onto poly(acrylic acid)-b-
poly(D,L-lactide)-SCKs49. Hence, it seems that protein adsorption
and interactions between nanomaterials and biomolecules in the
surrounding environment depend not only on the polymeric coating,
although a critical factor, but also on other characteristics of nano-
particles (composition, size, zeta-potential, presence/absence of
crosslinks, type of corematerials, etc.). The neutral micelles adsorbed
low amounts of cytokines. Both anionic and cationic micelles and
SCKs adsorbed more cytokines than did the zwitterionic nanoparti-
cles. In particular, the cationic nanoparticles were associated with
higher protein adsorption, as compared to the anionic analogs. The
Figure 4 | Viability of cells (%) treated with non-ionic-, zwitterionic-,
cationic-, anionic-PPE micelles, zwitterionic-, cationic- and anionic-PPE
SCKs. The values are presented as mean 6 SD of at least triplicates. The
graphs that present Lipofectamine, PEI, Cremophor-EL, the degradation
products of the various PPE-based nanoparticles and various
combinations of nanoparticles are in the Supporting Information
(Figure S5).
www.nature.com/scientificreports
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cationic carriers are known to have higher capacity for interactions
with cells, proteins and biomolecules than neutral and anionic nano-
particles. For instance, Deng et al. have demonstrated that modifica-
tion of the surface charge of polymer-coated gold nanoparticles had a
great influence on the protein adsorption competences of the nano-
particles. Consistent with our results, they found that neutral nano-
particles had lower affinity for protein adsorption than did anionic
and cationic nanoparticles50.
Immunotoxicities of PPE-micelles and SCKs, and their degra-
dation products. Proinflammatory cytokines (e.g. IL-1, IL-6 and
TNF-a) serve as mediators of inflammatory and immunologic
reactions and activate functions of several inflammatory cells
during acute inflammatory responses9,51. The immunotoxicities of
the PPE micelles, SCKs and their degradation products were
studied by incubating RAW 264.7 mouse macrophages with the
various formulations (5 mg/mL) for 24 h, followed by measuring
the levels of 23 different cytokines using the previously established
multiplexing assay (Figure 5 and Tables S1–S4)49. The in vitro
immunotoxicity, evaluated by the number of induced cytokines,
for PPE micelles was highest for cationic micelles (13 cytokines)
and decreased according to zwitterionic (7 cytokines) . neutral (3
cytokines) . anionic micelles (1 cytokines). For the PPE SCKs,
immunotoxicity was also higher for cationic SCKs (12 cytokines)
than for anionic SCKs (3 cytokines), whereas the zwitterionic
SCKs did not induce the secretions of any of the tested cytokines.
These proinflammatory cytokines have been well studied and
characterized as participants in the basic inflammatory process and
mediators of cellular infiltration52–57. Degradation products of PPE-
micelles and SCKs inducedminimal release of the tested cytokines. A
similar pattern was observed for the degradation products of the
PEBP-b-PBYP backbone. Among all the tested formulations and
their degradation products, the three nanoparticles which induced
the release of most of the tested cytokines were cationic micelles and
SCKs and zwitterionic micelles. It is known that cationic carriers
interact rapidly and strongly with the membranes of cells and are
endocytosed to greater extents than are neutral or anionic carriers.
Surprisingly, zwitterionic micelles induced high release of the tested
cytokines (7 cytokines, Figure 5 and Table S3). Neutral micelles also
induced the release of several cytokines (Table S4). Remarkably, the
induction of cytokines was substantially reduced simply by the
introduction of crosslinks within the shells of the zwitterionic
micelles.
It has been reported previously that crosslinking can reduce the
cytotoxicity and immunotoxicity of polymericmicelle assemblies13,14.
Crosslinking of cationic micelles reduced their immunotoxicity
(Table S2). Furthermore, crosslinking of zwitterionicmicelles signifi-
cantly reduced the immunotoxicity of the PPE-nanoparticles (Table
S3). However, there is an observed increase in cytotoxicity and
immunotoxicity upon crosslinking anionic PPE-micelles (Table
S1). This effect might be due to the higher stability of the SCKs
against degradation (See Figure S2). Because the degradation pro-
ducts of both the anionic micelles and SCKs have limited immuno-
toxicity, the faster degradation of the micelles into the less-cytotoxic
and -immunotoxic degradation products may explain the lower
immunotoxicity of the parent micelles as compared to the parent
SCKs. A similar trend was observed in terms of cytotoxicity (vide
supra, IC50 values of 1705 6 16 vs. 761 6 38 for anionic micelles vs.
anionic SCKs, respectively, Table 1).
Discussion
PPE-based micelles and crosslinked nanoparticles with various sur-
face charges, which have been designed for a variety of biomedical
applications (non-ionic, anionic, and zwitterionic surface character-
istics for packaging and delivery of therapeutics to treat infectious
diseases or cancer, and cationic for delivery of nucleic acids for theT
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treatment of inflammatory diseases or cancer)8,18,58–60, were con-
structed using a quick and efficient synthetic strategy, and impor-
tantly, demonstrated remarkable differences in terms of cytotoxicity,
immunotoxicity, and anti-biofouling properties, as a function of
their surface charge characteristics and also with dependence on
crosslinking throughout the shell layers. Themicelles and their cross-
linked analogs demonstrated lower cytotoxicity than several com-
mercially-available vehicles, with crosslinking of the cationicmicelles
being highly efficient in further reducing the cytotoxicity of the
micelles. The key conclusion from this study is that every nanopar-
ticle should be rigorously investigated on individual basis and
generalization can be seriously misleading, as the behavior of nano-
particles and their forming polymers differs significantly from one
type of nanoparticle to another. In these particular PPE-based
degradable nanoparticles, crosslinking has proven to play an import-
ant role in controlling stability, cytotoxicity and immunotoxicity of
some of the characterized nanoparticles. In particular, zwitterionic
micelles and SCKs and their degradation products exhibited
exceptional safety profiles, with no cytotoxicity observed up to a
concentration of 3000 mg/mL and without adsorbing any of the
tested cytokines. In addition, crosslinking of zwitterionic micelles
significantly reduced the immunotoxicity, as evidenced from the
absence of secretions of any of the 23 cytokines, whereas the micellar
counterpart induced the release of 7 cytokines from RAW 264.7
mouse macrophages treated with the nanoparticles. The degradation
products of PPE-micelles and their crosslinked analogs were not
cytotoxic and induced low immunotoxicity. These nanoparticles
are currently being exploited for delivery of various therapeutics
(e.g. nucleic acids and antimicrobial agents), and for administration
via various routes, such as inhalational therapy. Moreover, with the
convenient ability to tune the surface chemistry, these nanomaterials
have the possibility of being expanded into highly complex hierarch-
ically-assembled theranostics40. Future in vitro and in vivo character-
izations of these nanoparticles and their utilization for delivery of
various drugs, and decoration with targeting moieties will broaden
their applications in clinical nanomedicine.
Methods
Details of experimental procedures and characterizations are included in the sup-
porting information.
1. Self-assembly of functional diblock copolymers. The functional diblock
copolymers (5.0 mg) were suspended into nanopure water (1.0 mL) and sonicated
for 10 min.
The anionic diblock copolymers (30.0 mg, 0.100 mmol of acrylic acid) were sus-
pended into ultrapure water (6.0 mL) and sonicated for 10 min. After being stirred
for 1 h, a clear solution containing the anionic micelles was obtained. To a stirred
solution of anionic micelle in a round-bottom flask equipped with a stir bar was
added, dropwisely over 10 min, a solution of 2,29-(ethylenedioxy)bis(ethylamine)
(2.2 mg, 0.015 mmol) in ultrapure water (1.0 mL). The solution was allowed to stir
for 1 h at room temperature. To this reaction mixture was added dropwisely, via a
metering pump at the rate of 2 mL/h, a solution of EDCI (9.8 mg, 0.035 mmol)
dissolved in ultrapure water (2 mL). The reaction mixture was allowed to stir over-
night at room temperature and was then transferred to presoaked dialysis membrane
tubes (MWCO ca. 6–8 kDa), and dialyzed against nanopurewater for 36 h in the cold
room (4–8uC) to remove small molecules. Final concentration of anionic SCK solu-
tion was adjusted to 2.5 mg/mL by the buffer solution to the desired pH or by
ultrapure water. The anionic SCKs solution was lyophilized into powder and kept in
the freezer (220uC) for long term storage before being tested.
The cationic diblock copolymers (30.0 mg, 0.097 mmol of amino group) were
suspended into ultrapure water (6.0 mL) and sonicated for 10 min. After being
stirred for 1 h, a clear solution containing the cationic micelles was obtained. A
solution of the diacid crosslinker (Bis-dPEGH2-acid, 3.0 mg, 0.015 mmol) in ultra-
pure water (1.0 mL) was added dropwisely to a stirred solution of micelle in a 5-mL
vial. The mixture solution was allowed to stir for 1 h at room temperature. To this
reaction mixture was added dropwisely, via a metering pump at the rate of 2 mL/h, a
solution of EDCI (9.8 mg, 0.035 mmol) dissolved in ultrapure water (2 mL). The
reaction mixture was allowed to stir overnight at room temperature and was then
transferred to presoaked dialysis membrane tubes (MWCO ca. 6–8 kDa), and dia-
lyzed against ultrapure water for 36 h in the cold room (4–8uC) to remove small
molecules. Final concentration of cationic SCKs was adjusted to 2.5 mg/mL by the
buffer solution to the desired pH or by ultrapure water. The cationic SCKs solution
was lyophilized into powder and kept in the freeze (220uC) for the long term storage
and transportation before being tested.
The zwitterionic diblock copolymers (30.0 mg, 0.081 mmol of acrylic acid,
0.081 mmol of amino group) were suspended into ultrapure water (6.0 mL) and
sonicated for 10 min. After being stirred for 1 h, a clear solution containing the
zwitterionic micelles was obtained. To this micelle solution was added dropwisely a
solution of EDCI (7.2 mg, 0.027 mmol) dissolved in ultrapure water (2 mL). The
reaction mixture was allowed to stir overnight at room temperature and was then
transferred to presoaked dialysis membrane tubes (MWCO ca. 6–8 kDa), and dia-
lyzed against ultrapure water for 36 h in the cold room (4–8uC) to remove small
molecules. Final concentration of zwitterionic SCKs was adjusted to 2.5 mg/mL by
the buffer solution to the desired pH or by ultrapure water. The zwitterionic SCKs
solution was lyophilized into powder and kept in the freeze (220uC) for the long term
storage and transportation before being tested.
2. Degradation studies. In a typical degradation experiment, a solution of
nanoparticles (micelles or SCKs) was adjusted to pH 5.0 or pH 7.4 by 150 mM PBS
buffer. The mixture solution was incubated in the 37uC shaker. The size, size
distribution and zeta potential were measured by Delsa Nano C particle analyzer
during the degradation.
For the cytotoxicity and immunotoxicity studies, a solution of nanoparticles
(micelles or SCKs, 2.5 mg/mL, 8 mL) was adjusted to pH 7.4 by PBS buffer (12 mM,
2 mL, without NaCl or KCl) and incubated in a shaker at 37uC for 20 weeks. After
Table 2 | Cytokines adsorption on anionic, cationic, neutral and
zwitterionic micelles, and the anionic, cationic and zwitterionic
SCKs. The adsorption of cytokines was calculated based on appar-
ent concentrations of cytokines measured when incubated with
nanoparticles, as compared to their concentrations in a solution
treated in the same way but containing no nanoparticles. The indi-
cated p values highlight the significance of differences between
the measured concentrations of the treatment and the control, and
only cytokines of p values less than 0.05 are shown in the table
Nanoparticles Adsorbed cytokines p value
Anionic micelles IL-12(p40) 0.0002
IL-17 0.002
IFN-c 0.03
Cationic micelles IL-1a 0.000009
IL-17 0.00002
IL-4 0.00002
MIP-1b 0.00007
IL-2 0.00008
KC 0.0002
IL-12(p40) 0.0003
IL-9 0.003
IL-12(P70) 0.004
IL-1b 0.005
IL-3 0.01
IFN-c 0.02
RANTES 0.02
MIP-1a 0.04
Zwitterionic micelles
Non-ionic micelles MIP-1b 0.002
IL-9 0.02
RANTES 0.04
Anionic SCKs IL-17 0.003
IL-12(p40) 0.007
Eotaxin 0.04
IL-10 0.04
Cationic SCKs IL-2 0.0002
MIP-1b 0.0005
IL-12(p40) 0.0007
IL-9 0.0009
KC 0.0009
IL-1a 0.001
IL-12(p70) 0.004
RANTES 0.005
IL-13 0.01
IL-17 0.01
Eotaxin 0.02
IL-4 0.02
Zwitterionic SCKs IL-12(p40) 0.001
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fully degradation of nanoparticles, the solutions were lyophilized into powder before
being tested. For the degradation of PEBP-b-PBYP backbone, 10 mg of PEBP-b-
PBYP backbone was soaked in the pH 2 sodium hydroxide solution and incubated in
the 37uC shaker for 20 weeks. After a clear solution was formed, the solution was
adjusted to pH 7.0 and lyophilized into powder before being tested.
3. Cytotoxicity assay. The cytotoxicity assay has been carried out as reported
previously58. RAW 264.7 (2 3 104 cells/well) mouse macrophages were plated in 96-
well plate in Dulbecco’s Modified Eagle Medium (DMEM) (10% fetal bovine serum
and 1% penicillin/streptomycin). Cells were incubated at 37 uC in a humidified
atmosphere containing 5% CO2 for 24 h to adhere. Then, the medium was replaced
with a fresh medium 1-h prior to the addition of 20 mL of the PPEmicelles, SCKs and
their degradation products, Lipofectamine, PEI and Cremophor-EL to 100 mL of the
medium (final concentrations ranged from 0.7–166.7 mg/mL for Lipofectamine and
PEI, 20–10,000 mg/mL for Cremophor-EL and 6–3000 mg/mL for PPE formulations).
The cells were incubated with the formulations for 24 h and washed once with PBS
and 100 mL of the complete media was added to the cells. MTS combined reagent
(20 mL) was added to each well (Cell Titer 96H Aqueous Non-Radioactive Cell
Proliferation Assay, Promega Co., Madison, WI). The cells were incubated with the
reagent for 2 h at 37 uC in a humidified atmosphere containing 5% CO2 protected
from light. Absorbance was measured at 490 nm using SpectraMax M5 (Molecular
Devices Co., Sunnyvale, CA). Cell viability was calculated based on the relative
absorbance to the control-untreated cells. The calculation of the IC50 values and the
statistical analysis were performed using GraphPad Prism four-parameter fit,
considering the 0% and 100% cell viabilities are for the control medium (no cells) and
cells with no treatment, respectively.
4. Multiplex assay. The multiplex assay has been performed as reported previously58.
The RAW 264.7 cells were treated with medium (control), PPE micelles, SCKs and
their degradation products (5 mg/mL) for 24 h. The supernatants were then collected
and centrifuged for 10 min at 13,000 rpm. Serial dilutions of cytokine standards were
also prepared in the same diluent utilized for the samples (i.e. cell-culture medium).
Control, standards and nanoparticle-treated samples (50 mL) were incubated with
antibody-conjugated magnetic beads for 30 min in the dark. After washing, the
detection antibody was added to the wells and incubated in the dark for 30 min under
continuous shaking (300 rpm). After washing, streptavidin-phycoerythrinwas added
to each well and incubated while protected from light for 10 min under the same
shaking conditions. Finally, after several washings and re-suspension in the assay
buffer and shaking, the expression of themouse cytokines, interleukin (IL)-1a, IL-1b,
IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (P40), IL-12 (P70), IL-13, IL-17, Eotaxin,
granulocyte-colony-stimulating factor (G-CSF), granulocyte macrophage-colony-
stimulating factor (GM-CSF), interferon-c (IFN-c), keratinocyte-derived chemokine
(KC), monocyte chemotactic protein (MCP)-1, macrophage inflammatory protein
(MIP)-1a, MIP-1b, regulated upon activation normal T-cell expressed and
presumably secreted (RANTES) and tumor necrosis factor-a (TNF-a) was measured
immediately using Bioplex 200 system with HTF and Pro II Wash station (Bio-Rad
Laboratories, Inc., Hercules, CA) and the data was analyzed using the Bioplex Data
Pro software.
5. Protein adsorption assay. Adsorption of the mouse cytokines, IL-1a, IL-1b, IL-2,
IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (P40), IL-12 (P70), IL-13, IL-17, Eotaxin, G-
CSF, GM-CSF, IFN-c, KC, MCP-1, MIP-1a, MIP-1b, RANTES and TNF-a by PPE
micelles and SCKs, was measured using a Bioplex 200 system with HTF and Pro II
Wash station. Specific concentrations of the standards of each cytokine were
determined either in cell culture medium (the same medium used in the multiplex
assay section) or whenmixed with the various nanoparticles (500 mg/mL) in the same
medium, as has been described in the previous section. The values are presented as the
ratio of the cytokines in the cytokines/nanoparticles mixture to the solution that
contains the same amount of the cytokines but without the nanoparticles.
6. Endotoxin assay.The endotoxin contents of the various samples weremeasured by
using the PierceH Limulus Amebocyte Lysate (LAL) Chromogenic Endotoxin
Quantitation Kit, according to the manufacturer instructions and as described
previously14. Briefly, all reagents were equilibrated to the room temperature, while the
96-well microplate was maintained at 37uC. To each well, 50 mL of each endotoxin
standards, blank (endotoxin-free water), PPE micelles, SCKs and their degradation
products was dispensed and the plate was covered and incubated for 5 min at 37uC.
Then, 50 mL of LAL was added to each well, gently agitated for 10 seconds and
incubated again for 10 min at 37uC, followed by the addition of 100 mL of substrate
solution. After gentle agitation and incubation for 6 min at 37uC, 50 mL of 25% acetic
acid (stop reagent) was added to each well and the absorbance was measured at
405 nm using SpectraMax M5. The concentration of endotoxin in the standards and
samples was determined after constructing a standard curve from the corrected
absorbance values.
7. Statistical analysis. Values are presented as mean 6 SD of at least three
independent experiments. Significance of the differences between two groups was
evaluated by Student’s t test (unpaired) or betweenmore than two groups by one-way
ANOVA followed by Tukey’s multiple comparison tests. Differences between
different groups were considered significant for p values less than 0.05.
1. Perry, J. L., Herlihy, K. P., Napier, M. E. & Desimone, J. M. PRINT: a novel
platform toward shape and size specific nanoparticle theranostics.Acc. Chem. Res.
44, 990–998 (2011).
2. vonMaltzahn, G. et al. Nanoparticles that communicate in vivo to amplify tumour
targeting. Nat. Mater. 10, 545–552 (2011).
3. Elsabahy, M. & Wooley, K. L. Design of polymeric nanoparticles for biomedical
delivery applications. Chem. Soc. Rev. 41, 2545–2561 (2012).
4. Rolland, J. et al. Polyelectrolyte complex nanoparticles from chitosan and
poly(acrylic acid) and Polystyrene-block-poly(acrylic acid). J. Polym. Sci. Part A:
Polym. Chem. 50, 4484–4493 (2012).
5. Dobrovolskaia, M. A. & McNeil, S. E. Immunological properties of engineered
nanomaterials. Nat. Nanotechnol. 2, 469–478 (2007).
6. Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A. & McNeil, S. E.
Nanoparticle interaction with plasma proteins as it relates to particle
biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev.
61, 428–437 (2009).
Figure 5 | The number of induced cytokines following treatment of RAW 264.7 mouse macrophages with PPE-micelles and SCKs of various surface
charges (non-ionic, cationic, anionic and zwitterionic), and their degradation products at 5 mg/mL for 24 h. The 23measured cytokines were IL-1a, IL-
1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (P40), IL-12 (P70), IL-13, IL-17, Eotaxin, G-CSF, GM-CSF, IFN-c, KC, MCP-1, MIP-1a, MIP-1b,
RANTES and TNF-a.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 3 : 3313 | DOI: 10.1038/srep03313 8
7. Samarajeewa, S., Shrestha, R., Li, Y. & Wooley, K. L. Degradability of poly(Lactic
Acid)-containing nanoparticles: Enzymatic access through a cross-linked shell
barrier. J. Am. Chem. Soc. 134, 1235–1242 (2012).
8. Samarajeewa, S. et al. In vitro efficacy of paclitaxel-loaded dual-responsive shell
cross-linked polymer nanoparticles having orthogonally degradable disulfide
cross-linked corona and polyester core domains. Mol. Pharm. 10, 1092–1099
(2013).
9. Elsabahy, M. & Wooley, K. L. Cytokines as biomarkers of nanoparticle
immunotoxicity. Chem. Soc. Rev. 42, 5552–5576 (2013).
10. Deng, Z. J., Liang, M., Monteiro, M., Toth, I. & Minchin, R. F. Nanoparticle-
induced unfolding of fibrinogen promotes Mac-1 receptor activation and
inflammation. Nat. Nanotechnol. 6, 39–44 (2011).
11. Tan, Y., Li, S., Pitt, B. R. & Huang, L. The inhibitory role of CpG
immunostimulatory motifs in cationic lipid vector-mediated transgene
expression in vivo. Hum. Gene. Ther. 10, 2153–2161 (1999).
12. Elsabahy, M. & Wooley, K. L. Strategies toward well-defined polymer
nanoparticles inspired by nature: chemistry versus versatility. J. Polym. Sci. Part A:
Polym. Chem. 50, 1869–1880 (2012).
13. Klyachko, N. L. et al. Cross-linked antioxidant nanozymes for improved delivery
to CNS. Nanomedicine 8, 119–129 (2012).
14. Elsabahy, M., Samarajeewa, S., Raymond, J. E., Clark, C. & Wooley, K. L. Shell-
crosslinked knedel-like nanoparticles induce lower immunotoxicity than their
non-crosslinked analogs. J. Mater. Chem. B 1, 5241–5255 (2013).
15. Silvers, A. L., Chang, C. C. & Emrick, T. Functional aliphatic polyesters and
nanoparticles prepared by organocatalysis and orthogonal grafting chemistry.
J. Polym. Sci. Part A: Polym. Chem. 50, 3517–3529 (2012).
16. Tan, J. H. et al. Hyperbranched polymers as delivery vectors for oligonucleotides.
J. Polym. Sci. Part A: Polym. Chem. 50, 2585–2595 (2012).
17. Zhang, S. et al. Rapid and versatile construction of diverse and functional
nanostructures derived from a polyphosphoester-based biomimetic block
copolymer system. J. Am. Chem. Soc. 134, 18467–18474 (2012).
18. Shen, Y. et al. Polyphosphoester-based cationic nanoparticles serendipitously
release integral biologically-active components to serve as novel degradable
inducible nitric oxide synthase inhibitors. Adv. Mater. 25, 5609–5614 (2013).
19. Zhang, S., Li, A., Zou, J., Lin, L. Y. & Wooley, K. L. Facile synthesis of clickable,
water-soluble and degradable polyphosphoesters. ACS Macro Lett. 1, 328–333
(2012).
20. Hunt, J. N. et al. Tunable, high modulus hydrogels driven by ionic coacervation.
Adv. Mater. 23, 2327–2331 (2011).
21. Baran, J. & Penczek, S. Hydrolysis of polyesters of phosphoric-acid. 1. kinetics and
the pH profile. Macromolecules 28, 5167–5176 (1995).
22. Yang, X.-Z., Wang, Y.-C., Tang, L.-Y., Xia, H. & Wang, J. Synthesis and
characterization of amphiphilic block copolymer of polyphosphoester and
poly(L-lactic acid). J. Polym. Sci. Part A: Polym. Chem. 46, 6425–6434 (2008).
23. Liu, J. et al. Hyperbranched polyphosphates for drug delivery application: design,
synthesis, and in vitro evaluation. Biomacromolecules 11, 1564–1570 (2010).
24. Wang, Y.-C., Tang, L.-Y., Li, Y. & Wang, J. Thermoresponsive block copolymers
of poly(ethylene glycol) and polyphosphoester: thermo-induced self-assembly,
biocompatibility, and hydrolytic degradation. Biomacromolecules 10, 66–73
(2008).
25. Iwasaki, Y. & Akiyoshi, K. Design of biodegradable amphiphilic polymers: well-
defined amphiphilic polyphosphates with hydrophilic graft chains via ATRP.
Macromolecules 37, 7637–7642 (2004).
26. Iwasaki, Y., Nakagawa, C., Ohtomi, M., Ishihara, K. & Akiyoshi, K. Novel
biodegradable polyphosphate cross-linker for making biocompatible hydrogel.
Biomacromolecules 5, 1110–1115 (2004).
27. He, J. et al. Synthesis and physicochemical characterization of biodegradable and
pH-responsive hydrogels based on polyphosphoester for protein delivery.
J. Polym. Sci. Part A: Polym. Chem. 48, 1919–1930 (2010).
28. Du, J.-Z., Sun, T.-M., Weng, S.-Q., Chen, X.-S. & Wang, J. Synthesis and
characterization of photo-cross-linked hydrogels based on biodegradable
polyphosphoesters and poly(ethylene glycol) copolymers. Biomacromolecules 8,
3375–3381 (2007).
29.Wang, J., Mao, H.-Q. & Leong, K.W. A novel biodegradable gene carrier based on
polyphosphoester. J. Am. Chem. Soc. 123, 9480–9481 (2001).
30. Lu, Z.-Z. et al. Biodegradable polycation and plasmid DNA multilayer film for
prolonged gene delivery to mouse osteoblasts. Biomaterials 29, 733–741 (2008).
31. Du, J.-Z. et al. Synthesis and micellization of amphiphilic brush-coil block
copolymer based on poly(e-caprolactone) and PEGylated polyphosphoester.
Biomacromolecules 7, 1898–1903 (2006).
32. Wang, Y.-C. et al. Self-assembled micelles of biodegradable triblock copolymers
based on poly(ethyl ethylene phosphate) and poly( -caprolactone) as drug
carriers. Biomacromolecules 9, 388–395 (2007).
33. Wachiralarpphaithoon, C., Iwasaki, Y. & Akiyoshi, K. Enzyme-degradable
phosphorylcholine porous hydrogels cross-linked with polyphosphoesters for cell
matrices. Biomaterials 28, 984–993 (2007).
34. Shao, H., Zhang, M., He, J. & Ni, P. Synthesis and characterization of amphiphilic
poly(e-caprolactone)-b-polyphosphoester diblock copolymers bearing
multifunctional pendant groups. Polymer 53, 2854–2863 (2012).
35. Wang, Y.-C. et al. Engineering nanoscopic hydrogels via photo-crosslinking salt-
induced polymer assembly for targeted drug delivery. Chem. Commun. 46,
3520–3522 (2010).
36. Xiong, M.-H. et al. Synthesis of PEG-armed and polyphosphoester core-cross-
linked nanogel by one-step ring-opening polymerization. Macromolecules 42,
893–896 (2009).
37. Xiong, M.-H. et al. Bacteria-responsive multifunctional nanogel for targeted
antibiotic delivery. Adv. Mater. 24, 6175–6180 (2012).
38. Zou, J. et al. pH-Triggered reversible morphological inversion of orthogonally-
addressable poly(3-acrylamidophenylboronic acid)-block-
poly(acrylamidoethylamine) micelles and their shell crosslinked nanoparticles.
J. Polym. Sci. Part A: Polym. Chem. 3, 3146–3156 (2012).
39. Samarajeewa, S. et al. Degradable cationic shell cross-linked knedel-like
nanoparticles: Synthesis, degradation, nucleic acid binding, and in vitro
evaluation. Biomacromolecules 14, 1018–1027 (2013).
40. Elsabahy, M. et al. Multifunctional hierarchically assembled nanostructures as
complex stage-wise dual-delivery systems for coincidental yet differential
trafficking of siRNA and paclitaxel. Nano Lett. 13, 2172–2181 (2013).
41. Huang, S. J., Wang, T. P., Lue, S. I. & Wang, L. F. Pentablock copolymers of
pluronic F127 and modified poly(2-dimethyl amino)ethyl methacrylate for
internalization mechanism and gene transfection studies. Int. J. Nanomedicine 8,
2011–2027 (2013).
42. Zhang, G., Liu, J., Yang, Q., Zhuo, R. & Jiang, X. Disulfide-containing brushed
polyethylenimine derivative synthesized by click chemistry for nonviral gene
delivery. Bioconjug. Chem. 23, 1290–1299 (2012).
43. Val, S. et al. Carbon black and titanium dioxide nanoparticles induce pro-
inflammatory responses in bronchial epithelial cells: need for multiparametric
evaluation due to adsorption artifacts. Inhal. Toxicol. 21, 115–122 (2009).
44. Kocbach, A., Totlandsdal, A. I., Lag, M., Refsnes, M. & Schwarze, P. E. Differential
binding of cytokines to environmentally relevant particles: a possible source for
misinterpretation of in vitro results? Toxicol. Lett. 176, 131–137 (2008).
45. Li, A. et al. Synthesis and in vivo pharmacokinetic evaluation of degradable shell
cross-linked polymer nanoparticles with poly(carboxybetaine) versus
poly(ethylene glycol) surface-grafted coatings. ACS Nano 6, 8970–8982 (2012).
46. Keefe, A. J. & Jiang, S. Poly(zwitterionic)protein conjugates offer increased
stability without sacrificing binding affinity or bioactivity.Nature Chem. 4, 59–63
(2012).
47. Rodriguez-Emmenegger, C. et al. Polymer brushes showing non-fouling in blood
plasma challenge the currently accepted design of protein resistant surfaces.
Macromol. Rapid Commun. 32, 952–957 (2011).
48. Jiang, S. & Cao, Z. Ultralow-fouling, functionalizable, and hydrolyzable
zwitterionic materials and their derivatives for biological applications. Adv.
Mater. 22, 920–932 (2010).
49. Elsabahy, M. et al. Differential immunotoxicities of poly(ethylene glycol)- vs.
poly(carboxybetaine)-coated nanoparticles. J. Control. Release 10.1016/
j.jconrel.2013.1009.1010 (2013).
50. Deng, Z. J., Liang, M., Toth, I., Monteiro, M. & Minchin, R. F. Plasma protein
binding of positively and negatively charged polymer-coated gold nanoparticles
elicits different biological responses. Nanotoxicology 7, 314–322 (2013).
51. Benjamini, E., Coico, R. & Sunshine, G. in Immunology (ed. Margulies, D. H.)
(John Wiley & Sons, Inc., New York, 2000).
52. Zhang, L. W., Yu, W. W., Colvin, V. L. & Monteiro-Riviere, N. A. Biological
interactions of quantum dot nanoparticles in skin and in human epidermal
keratinocytes. Toxicol. Appl. Pharmacol. 228, 200–211 (2008).
53. Ryman-Rasmussen, J. P., Riviere, J. E. &Monteiro-Riviere, N. A. Surface coatings
determine cytotoxicity and irritation potential of quantum dot nanoparticles in
epidermal keratinocytes. J. Invest. Dermatol. 127, 143–153 (2007).
54. Beyerle, A., Irmler, M., Beckers, J., Kissel, T. & Stoeger, T. Toxicity pathway
focused gene expression profiling of PEI-based polymers for pulmonary
applications. Mol. Pharm. 7, 727–737 (2010).
55. Powers, M. R., Davies, M. H. & Eubanks, J. P. Increased expression of chemokine
KC, an interleukin-8 homologue, in a model of oxygen-induced retinopathy.
Curr. Eye Res. 30, 299–307 (2005).
56. Kim, B. H., Lee, Y. S. & Kang, K. S. The mechanism of retinol-induced irritation
and its application to anti-irritant development. Toxicol. Lett. 146, 65–73 (2003).
57. Cubillos-Ruiz, J. R. et al. Polyethylenimine-based siRNA nanocomplexes
reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic
antitumor immunity. J. Clin. Invest. 119, 2231–2244 (2009).
58. Shrestha, R., Elsabahy, M., Florez-Malaver, S., Samarajeewa, S. & Wooley, K. L.
Endosomal escape and siRNA delivery with cationic shell crosslinked knedel-like
nanoparticles with tunable buffering capacities. Biomaterials 33, 8557–8568
(2012).
59. Shah, P. N. et al. Synthesis, characterization, and in vivo efficacy of shell cross-
linked nanoparticle formulations carrying silver antimicrobials as aerosolized
therapeutics. ACS Nano 7, 4977–4987 (2013).
60. Ibricevic, A. et al. PEGylation of cationic, shell-crosslinked-knedel-like
nanoparticles modulates inflammation and enhances cellular uptake in the lung.
Nanomedicine doi: 10.1016/j.nano.2013.02.006 (2013).
Acknowledgments
We gratefully acknowledge financial support from the National Heart Lung and Blood
Institute of the National Institutes of Health as a Program of Excellence in Nanotechnology
(HHSN268201000046C), the National Institute of Diabetes and Digestive and Kidney
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 3 : 3313 | DOI: 10.1038/srep03313 9
Diseases of the National Institutes of Health (R01-DK082546), and the National Science
Foundation under grant number DMR-0906815 and DMR-1105304. The Welch
Foundation is gratefully acknowledged for support through theW. T.Doherty-WelchChair
in Chemistry, Grant No. A-0001. The transmission electron microscopy facilities at
Washington University in St. Louis, Department of Otolaryngology, and Research Center
for Auditory and Visual Studies funded by NIH P30 DC004665 are gratefully
acknowledged. ZJD acknowledges a Fellowship support from the NHMRC. PTH
acknowledges support as David H. Koch Chair.
Author contributions
M.E. and S.Z. designed the project, performed the experiments and wrote the manuscript.
F.Z., Y.H.L., H.W. and P.P. helped out with the experiments. Z.J.D. and P.T.H. participated
in the analysis and discussion of the results and in writing the manuscript. K.L.W. designed
the study, wrote the manuscript and supervised the project. All authors reviewed the
manuscript.
Additional information
Supplementary information accompanies this paper at http://www.nature.com/
scientificreports
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Elsabahy, M. et al. Surface Charges and Shell Crosslinks Each Play
Significant Roles in Mediating Degradation, Biofouling, Cytotoxicity and Immunotoxicity
for Polyphosphoester-based Nanoparticles. Sci. Rep. 3, 3313; DOI:10.1038/srep03313
(2013).
This work is licensed under a Creative Commons Attribution-
NonCommercial-NoDerivs 3.0 Unported license. To view a copy of this license,
visit http://creativecommons.org/licenses/by-nc-nd/3.0
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 3 : 3313 | DOI: 10.1038/srep03313 10
